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Introduction Introduction Introduction Introduction Introduction
Benzalkonium chloride (BAK) is a cationic detergent expressing a high affinity to membrane proteins. It changes the ionic resistance of the cell membranes [1] . BAK, due to its antibacterial activities, is widely used especially in ophthalmology and dentistry. Its concentration in oral disinfectant mouthwash can reach as much as 10% [2] whereas in eye drops it varies between 0.004-0.05% [3] . Due to chronicity and widespread use of such treatments, BAK's side effects are of great importance. BAK's toxicity, probably related to its pro-oxidative activities [2] , is timeand dose-dependent. It also causes protein denaturation and disruption of the cytoplasmatic membranes [1] . This phenomenon could be helpful in increasing the penetrative abilities of the ophthalmologic solution's active compounds [4, 5] . Moreover, some of the active ophthalmological compounds e.g. prostaglandins exert a protective effect against the cytotoxicity of BAK [1, [6] [7] [8] . BAK can also decrease expression of MUC5AC on conjunctival cells, causing mucin deficiency and dry eyes in patients undergoing prolonged topical ophthalmic therapy [1, 6] and influence the generation of inflammation. Conjunctival expression of intercellular adhesion molecule-1 (ICAM-1, CD54), platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) and HLA-DR could be increased after their contact with BAK attracting and activating lymphocytes [1, 7] . In our recent publication, we showed that eight different commercially available anti-glaucoma topi-226 226 226 226 226 D P D P D P D P D Pozarowska, P P ozarowska, P P ozarowska, P P ozarowska, P P ozarowska, P Pozarowski ozarowski ozarowski ozarowski ozarowski BAK experiments. Benzalkonium chloride (BAK) was purchased from Sigma. 5% (~140 mM) stock solution of BAK was prepared in distilled water and stored in a refrigerator for a couple of days. BAK stock solution was administered directly into the culture flasks to obtain the final concentration, as indicated in the text and in the figure captions. BAK's influence on cells was checked in the range between 0.000001-0.5% (28 nM-14 mM). In key concentrations, experiments were performed in at least five repetitions.
V V V V Viability experiments
iability experiments iability experiments iability experiments iability experiments. Propidium iodide (PI) (Sigma) was added to the cell suspension collected directly from the culture flask at a final concentration of 1 μg/ml. After a short incubation, the cells were analyzed in a flow cytometer (FACSCalibur, BD Biosciences) equipped with a 488 nm laser. Specific PI fluorescence was measured as FL3. FCS low/PI + cells were considered as dead, and FCS high/PI -cells as live.
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Cell cycle experiments. The cells, treated with different concentrations of medications for various time intervals as indicated in the 'Results' section, were stained with acridin orange (AO) and subsequently analyzed by flow cytometry, as described previously [10, 11] . Using acridin orange assay enabled us to measure both RNA and DNA content in a single cell. This is crucial, not only for cell cycle positioning, but also to distinguish between apoptosis and necrosis ( Figure 1 ). At least 10,000 cells were analyzed [10] [11] [12] . (Figure 2 ). Using BAK in the range between 0.00001-0.0001% (0.28--2.8 μM) slightly induces apoptosis in a dose-and timedependent mode (Figures 1, 3) . Jurkat cell median apoptosis after 48 hours of cultivation significantly increased from 8.3% seen in control to 17% in 0.0001% (2.8 μM) BAK concentration. BAK does not induce any type of cell death in concentrations lower than 0.00001% (0.28 μM) (data not shown). These results were confirmed by viability results. BAK showed dose-and time-dependent effects on the viability of Jurkat cells with almost no effect in concentrations lower than 0.00001% (0.28 μM) (data not shown) and a slight effect in the range between 0.00001-0.0001% (0.28-2.8 μM). Dramatic loss of viability was observed in concentrations higher than 0.0001% (2.8 μM) (Figure 2) .
No major cell cycle blocks as a result of BAK influence were seen in concentrations up to 0.0001% (2.8 μM) (Figure 3) . A slight but significant decrease of cell numbers in S phase seen in cultures with addition of 0.00003-0.0001% (1.4-2.8 μM) BAK, especially after 48 hours of cultivation, was observed. This phenomenon could be the result of BAK's cytostatic effect (Figure 3) . Due to rapid cell death, cell cycle analysis could not be performed in higher BAK concentrations.
Discussion
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Eye preservative turnover is very slow. The lipophilic nature of most of them causes them to bind to the ocular tissues immediately after application and prolongs their action for as long as hundreds of hours. The half-time of BAK elimination from the eye surface is approximately 20 hours [13, 14] . This is why we decided to use the long term culture model in this study. We showed that BAK induces necrosis (concentration > 0.0001%), apoptosis (concentration 0.00001-0.0001%) or has no major influence (concentration < 0.00001%) on Jurkat line cells. The Jurkat cell line originates from T lymphocytes. Although lymphocytes do not infiltrate the cornea in physiological conditions, they are present in other parts of the anterior segment of the eye as an anterior chamber or a conjunctiva in both physiological and pathological conditions and are a subject for BAK stimulation. Moreover, exposure to BAK increases permability of eye tissues [4, 5] www.fhc.viamedica.pl adhesion molecules helping lymphocytes to reach the site of inflammation, and also expression of HLA-DR, which is crucial for antigen presentation needed for lymphocyte activation [1, 7] . This data is supported by clinical observations showing an immunologic reaction with increased presence of lymphocytes, Langerhans cells and macrophages in patients subjected to chronic application of preservatives. Moreover, sometimes such inflammations can lead to subconjunctival fibrosis [15] . In our recent study, we showed that almost all examined commercially available anti-glaucoma medications decrease the number of corneal epithelial cells during their cultivation due to induction cell death and proliferation suppression [9] . This observation can be explained not only by the effect of active substances, but also by BAK action. Many other in vitro studies have shown that preservatives are cytotoxic, especially for the cells of the ocular surface: conjunctival and corneal epithelium and keratocytes [7, 9, 14, [16] [17] [18] [19] but also for the deeper ocular tissues (fibroblast of Tenon's capsule, cells of lens epithelium and trabecular meshwork) [15, 20] . Although the cytotoxic effect of BAK is well documented in patients [15] and on cultivated adherent cells, its influence on lymphocytes seems not to have been explored until this study. Lymphocytes seem to be very sensitive to the cytotoxic effect of BAK. Cytotoxic and proapoptotic BAK concentrations for corneal and conjunctiva cells are higher than seen in this study for lymphocytes, and vary between 0.0001 and 0.02%, but most of them are close to the latter figure [5, 7, 8, 14, 17, 18] . Huge differences in these concentrations are probably due to differences in methods of cell treatments by BAK (especially in treatment and recovery time) and sensitivities of assays. Trabecular meshwork cells also seem to be very sensitive to BAK stimulation: in concentrations as low as 0.00015%, it kills about 20% of cells [20] .
Our present data also shows minimal anti-proliferative BAK effect on lymphoid cells. The number of cells in S phase was slightly reduced in cultures (especially those lasting 48 hours) treated with a subtoxic dosage of BAC. This suggests that in clinical conditions, the proliferation of lymphocytes is more resistant for BAK suppressive influence than cells Figure 1 . Figure 1 . Figure 1 . Figure 1 . Figure 3 . Figure 3 . Figure 3 . Figure 3 . Jurkat cells were cultured in the absence or presence of benzalkonium chloride (BAK) at different concentrations for 24 or 48 hours, stained with acridine orange (AO) as described previously [10, 11] and subsequently analyzed via flow cytometry (FACSCalibur). Cell cycle distributions were calculated and are presented as distribution diagrams. Medians are marked as lines. Diagrams were prepared using GraphPad Prism software. Significant differences (p < 0.05) to the control are marked as * [5] . Proliferation of human corneal keratocytes has also been measured by [ 3 H] thymidine methodology. BAK at a concentration of 0.01 mg/ml significantly decreases the proliferation of such cells, whereas its lower concentration does not affect it [21] . It also should be stated that BAK influences superficial cells, e.g. corneal epithelial cells or conjunctival cells, in higher concentrations than on infiltrating lymphocytes, even including BAK's effect on increasing the permeability of eye tissue.
Our findings in this study do not confirm the suggestion that BAK can induce G2M block. Such blocks were observed in some human corneal line cells treated with commercial anti-glaucoma medication containing BAK [9] . This observation has not been confirmed in vitro by others on corneal cells [18] , primary gingival fibroblasts [2] or on lymphoid line cells in this study. Most likely, the G2M blocks observed in our previous publication were due to active compounds of ophthalmic medication and not due to BAK's influence, but studies on corneal epithelial cells still need to be performed. BAK does not induce G2M block enabling cell cycle progression and thus lymphocytes can proliferate and respond properly for antigen stimulation. It should be state however that Jurkat cells are neoplastic ones and they differ from normal ones.
In conclusion, we want to state that BAK is relatively toxic to lymphoid cells, especially causing necrosis. In lower concentrations, it also shows moderate apoptotic and minimal antiproliferative effect on such cells. Other eye cells, especially superficial ones such as corneal epithelial cells and conjunctival cells, seem to be more resistant to BAK treatment. This observation could suggest possible lymphoid dysfunction during intensive, prolonged topical BAK treatment, even at a dosage relatively non-toxic to epithelial eye cells. D P D P D P D P D Pozarowska, P P ozarowska, P P ozarowska, P P ozarowska, P P ozarowska, P Pozarowski ozarowski ozarowski ozarowski ozarowski
